1,25-(OH)2D-24 Hydroxylase (CYP24A1) Deficiency as a Cause of Nephrolithiasis
Author(s) -
Galiesterova,
May Christine V. Malicdan,
Kaori Yasuda,
Toshiyuki Sakaki,
Thierry Vilboux,
Carla Ciccone,
Ronald L. Horst,
Yan Huang,
Gretchen Golas,
Wendy J. Introne,
Marjan Huizing,
David R. Adams,
Cornelius F. Boerkoel,
Michael T. Collins,
William A. Gahl
Publication year - 2013
Publication title -
clinical journal of the american society of nephrology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.755
H-Index - 151
eISSN - 1555-905X
pISSN - 1555-9041
DOI - 10.2215/cjn.05360512
Subject(s) - cyp24a1 , hypercalciuria , nephrocalcinosis , vitamin d and neurology , medicine , endocrinology , vitamin d deficiency , parathyroid hormone , tubulopathy , calcitriol receptor , calcium , kidney disease , kidney
Elevated serum vitamin D with hypercalciuria can result in nephrocalcinosis and nephrolithiasis. This study evaluated the cause of excess 1,25-dihydroxycholecalciferol (1α,25(OH)2D3) in the development of those disorders in two individuals.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom